Brachytherapy C-Arm Tables Market - Global Forecast 2026-2032

List of Tables

The Brachytherapy C-Arm Tables Market is projected to grow by USD 160.13 million at a CAGR of 6.17% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 105.28 million
Estimated Year [2026]	USD 111.98 million
Forecast Year [2032]	USD 160.13 million
CAGR (%)	6.17%

Brachytherapy C-Arm Tables: Executive Summary

Brachytherapy C-arm tables support image-guided radiotherapy workflows by combining patient positioning with compatibility for mobile or integrated fluoroscopic imaging. Their relevance is tied to procedural accuracy, access to anatomy, radiation-safety practices, workflow efficiency, and interoperability with treatment-room equipment. Adoption decisions typically depend on clinical requirements, table movement and stability, imaging access, patient-load characteristics, infection-control needs, serviceability, and compliance with applicable medical-device regulations.

Workflow Integration Is Reshaping Table Requirements

The landscape is shifting from standalone procedural furniture toward coordinated treatment environments. Hospitals and specialist cancer centers increasingly assess tables as part of a broader workflow that includes imaging, applicators, treatment planning, anesthesia, sterilization, and electronic documentation. Important design priorities include precise positioning, unobstructed C-arm access, reliable locking and movement, ergonomic access for clinical teams, and compatibility with different procedural techniques.

Procurement is also becoming more attentive to lifecycle considerations. Buyers evaluate installation constraints, staff training, preventive maintenance, cleaning protocols, spare-part availability, and interoperability alongside initial functionality. These factors can influence operating continuity and total ownership burden without depending on a single clinical use case.

Artificial Intelligence Is Strengthening Planning and Operational Coordination

Artificial intelligence can affect brachytherapy workflows through image segmentation, anatomy identification, treatment-planning support, quality checks, and workflow coordination. When used with appropriate clinical oversight, these capabilities may help reduce repetitive tasks and support more consistent preparation of image-guided procedures.

For C-arm tables, the most immediate relevance is indirect: AI-enabled imaging and planning increase the value of stable, repeatable patient positioning and dependable data exchange. Manufacturers and providers should therefore prioritize documented interoperability, traceable software updates, cybersecurity controls, human review, and validation across diverse patient anatomies and operating conditions. AI should assist qualified professionals rather than replace clinical judgment.

Regional Insights: Access, Infrastructure, and Regulation Shape Adoption

North America generally places strong emphasis on image-guided oncology, procedural efficiency, device integration, and documented regulatory compliance. Europe combines advanced cancer-care infrastructure with rigorous medical-device, quality, and data-governance expectations, while procurement often considers sustainability and cross-facility standardization.

Asia-Pacific presents varied conditions, ranging from highly specialized hospital systems to settings where capital investment, workforce capacity, and service coverage are more constrained. Latin America's adoption environment is influenced by uneven access to radiotherapy infrastructure, import processes, public-sector procurement, and specialist training. The Middle East is characterized by investment in tertiary healthcare and oncology capacity alongside differing reimbursement and localization requirements. Africa remains highly diverse, with access shaped by equipment availability, maintenance capability, workforce shortages, referral networks, and the concentration of specialized treatment services.

Group Insights: Economic and Security Blocs Influence Procurement Context

ASEAN markets reflect differing levels of oncology infrastructure, regulatory maturity, and dependence on imported medical equipment, making local service capability and training especially important. BRICS members span substantial differences in healthcare financing, manufacturing capacity, urban concentration, and access to specialist radiotherapy. The European Union emphasizes harmonized regulatory expectations, cross-border supply considerations, clinical quality, and procurement transparency.

G7 members typically assess advanced workflow integration, evidence, cybersecurity, service responsiveness, and lifecycle performance. GCC countries often prioritize modern tertiary-care capacity, specialist workforce development, and reliable vendor support. NATO members do not form a single healthcare procurement system, but many share interest in resilient supply chains, continuity of clinical operations, cybersecurity, and standardized quality processes.

Country Insights: Diverse Clinical and Procurement Priorities

Australia combines concentrated specialist services with strong expectations for safety, clinical governance, and service support. Brazil and Mexico must often balance advanced private or urban oncology capacity with unequal regional access and public procurement complexity. Canada emphasizes coordinated healthcare delivery, provincial procurement, and support for geographically dispersed facilities. China is characterized by a large and varied healthcare system, expanding domestic capability, and differing standards across institutions.

France, Germany, Italy, Spain, and the United Kingdom operate within mature clinical and regulatory environments where workflow evidence, interoperability, maintenance, and institutional procurement processes are important. India combines high-volume specialist centers with major variation in access, affordability, and infrastructure. Japan and South Korea place strong value on precision, reliability, advanced hospital technology, and regulatory compliance. Russia's operating environment is shaped by healthcare-infrastructure differences, procurement constraints, local support requirements, and supply-chain considerations. Across the United States, hospitals commonly emphasize regulatory documentation, integration with imaging and oncology systems, staff efficiency, cybersecurity, and dependable post-installation service.

Action Priorities for Leaders in Brachytherapy Table Procurement

Industry leaders should define requirements around complete clinical workflows rather than table specifications alone. A practical evaluation should test patient positioning, C-arm clearance, load performance, movement accuracy, imaging compatibility, cleaning access, anesthesia coordination, and emergency procedures under realistic conditions.

Leaders should also build a lifecycle plan covering commissioning, user training, preventive maintenance, software governance, cybersecurity, spare parts, and downtime response. Regional strategies should account for regulatory pathways, local technical capability, import and installation requirements, and differences in facility infrastructure. Finally, organizations should establish measurable acceptance criteria for positioning repeatability, workflow time, equipment availability, staff usability, and incident reporting before deployment.

Research Methodology: Evidence-Based Market Interpretation

This executive summary interprets the specified market category as equipment supporting brachytherapy procedures with C-arm imaging and patient-positioning functionality. The assessment uses the supplied product scope and general, verifiable considerations relevant to medical-device adoption, including clinical workflow, regulatory context, infrastructure, procurement, serviceability, interoperability, and responsible AI use.

No market estimates, market shares, forecasts, company-specific claims, or unverified performance assertions are used. Regional, group, and country observations are framed as contextual differences in healthcare systems, infrastructure, regulation, procurement, and workforce conditions rather than quantified measures of market activity.

Conclusion: Position Tables as Part of an Integrated Oncology Workflow

Brachytherapy C-arm tables are best evaluated as enabling components within image-guided oncology environments. Their practical value depends on positioning reliability, imaging access, ergonomic design, interoperability, safety, maintainability, and fit with local clinical workflows. Regional and country conditions can materially affect deployment priorities, particularly where specialist capacity, infrastructure, regulation, and technical support vary.

Organizations that combine clinically grounded specifications with lifecycle planning, validated integration, staff engagement, and responsible digital governance will be better positioned to select and operate these systems effectively. The strongest decisions will focus on dependable patient care and workflow resilience rather than isolated equipment features.

Product Code: MRR-094390F3CB4A

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Brachytherapy C-Arm Tables Market, by Product Type

7.1. Introduction
7.2. Fixed Table
- 7.2.1. Ceiling Mounted
- 7.2.2. Floor Mounted
7.3. Mobile Table
- 7.3.1. Compact Units
- 7.3.2. Portable Units

8. Brachytherapy C-Arm Tables Market, by Dose Rate

8.1. Introduction
8.2. High Dose Rate
8.3. Low Dose Rate

9. Brachytherapy C-Arm Tables Market, by Technology

9.1. Introduction
9.2. Analog
9.3. Digital
- 9.3.1. Flat Panel Detector
- 9.3.2. Image Intensifier

10. Brachytherapy C-Arm Tables Market, by End User

10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals
10.4. Specialty Clinics
- 10.4.1. Oncology Clinics
- 10.4.2. Radiology Clinics

11. Brachytherapy C-Arm Tables Market, by Application

11.1. Introduction
11.2. Interstitial
- 11.2.1. Gynecological Cancer
- 11.2.2. Prostate Cancer
11.3. Intracavitary
- 11.3.1. Esophageal
- 11.3.2. Gynecological
11.4. Surface
- 11.4.1. Eye Cancer
- 11.4.2. Skin Cancer

12. Brachytherapy C-Arm Tables Market, by Region

12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa

13. Brachytherapy C-Arm Tables Market, by Group

13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO

14. Brachytherapy C-Arm Tables Market, by Country

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
- 15.2.1. Concentration Ratio (CR)
- 15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Becton, Dickinson and Company
16.2. Best Medical International, Inc.
16.3. Biodex Medical Systems, Inc.
16.4. Canon Medical Systems Corporation
16.5. CIVCO Medical Solutions, Inc.
16.6. Eckert & Ziegler AG
16.7. Eckert & Ziegler BEBIG GmbH
16.8. Elekta AB
16.9. GE HealthCare Technologies Inc.
16.10. Hologic, Inc.
16.11. Koninklijke Philips N.V.
16.12. Modus Medical Devices Inc.
16.13. Oakworks, Inc.
16.14. Shimadzu Corporation
16.15. Siemens Healthineers AG
16.16. Varian Medical Systems, Inc.
16.17. Ziehm Imaging GmbH

17. Key Experts